Scientific Program – ART/IVF/Infertility

Friday, November 28 & Saturday, November 29, 2025

Friday, November 28

08:30-09:00 GOOD MORNING ROME PLENARY LECTURE HALL A
Capsule A decade ago, a pioneering procedure was successfully launched
Chairpersons Zion Ben Rafael, Israel
Rene Frydman, France
08:30-08:55 Pioneering uterus transplantation: Reflections on breakthroughs and deliveries
Mats Brännström, Sweden
08:55-09:00 Discussion

 

09:00-10:00 OVARIAN STIMULATION PRACTICES HALL A
Capsule Treatment of low and high responders
Chairpersons Zion Ben Rafael, Israel
Rene Frydman, France
09:00-09:30

09:00
09:10
09:20

Debate: Double trigger: When? Why? Does it work?

Yes: Edgardo Somigliana, Italy
No: Anja Pinborg, Denmark
Discussion
09:30-10:00

09:30
09:40
09:50

Debate: Should we go straight to IVF in women with anovulation due to PCOS?

Yes: Norbert Gleicher, USA
No: Stefano Palomba, Italy
Discussion

 

10:00-10:30 Coffee break, visit the exhibition, and e-poster viewing

 

10:30-12:00 PREPARATION FOR IVF HALL A
Capsule What is the effect of endometriosis screening and the use of PRP
Chairpersons Bart Fauser, Netherlands
Edgardo Somigliana, Italy
10:30-11:05

10:30
10:40
10:50

Debate: Should we screen for chronic endometritis before ART?

Yes: Ettore Cicinelli, Italy
No: Paul Pirtea, France
Discussion
11:05-11:40

11:05
11:15
11:25

Debate: The debate goes on: PRP for rejuvenation to improve ovarian response

Yes: Safety and efficacy based on a single centre experience Mattheos Fraidakis, Greece
No: Results of the PROVA RCT Norbert Gleicher, USA
Discussion
11:40-11:55 Ovulation trigger: How should we personalize?
Michael Grynberg, France
11:55-12:00 Discussion

 

12:00-12:05 Short break

 

12:05-13:05 INDUSTRY SUPPORTED SESSION HALL A

 

13:05-14:00 Lunch break, visit the exhibition, e-poster viewing, and moderated e-poster sessions

 

14:00-15:00 INDUSTRY SUPPORTED SESSION HALL A

 

15:00-15:05 Short break

 

15:05 – 16:35 LUTEAL PHASE SUPPORT HALL A 
Capsule How far should we support luteal phase?
Chairpersons

Basil Tarlatzis, Greece
Frank Broekmans, Netherlands
15:05-15:25

Oral, intravaginal, injectable progesterone
Dominique de Ziegler, France
15:25-15:30

Discussion
15:30-16:10

15:30
15:40
15:50

Debate: Are we losing embryos when applying day 5 culture for IVF?

Yes: Frank Broekmans, Netherlands
Opposition:  Paul Pirtea, France
Discussion
16:10-16:30

Progesterone supplementation, what else?
Stratis Kolibianakis, Greece
16:30-16:35

Discussion

 

16:35-17:00 Coffee break, visit the exhibition, and e-poster viewing

 

17:00-18:30

PGT UNDER CROSSFIRE?

 HALL A 
Capsule 

A class action lawsuit against genetic testing companies for misleading consumers about PGT – during IVF treatment was presented in the USA
Chairpersons 

Bart Fauser, Netherlands
Luca Gianaroli, Italy
17:00-17:30

17:00
17:10
17:20

Debate: Clinical perspective

Non-based ground: Antonio Capalbo, Italy
Based ground: Norber Gleicher,USA
Discussion
17:30-18:30

SPECIAL LECTURES
17:30-17:45

 

Linzagolix effect on bleeding and pain in patients with uterine fibroids: an analysis of the Primrose 1 and 2 trials
Felice Petraglia, Italy
17:45-17:50

Discussion
17:50-18:05

From life span to life health
Pasquale Patrizio, USA
18:05-18:10

Discussion
18:10-18:25

The challenges of defining success in ART
Luca Gianaroli, Italy
18:25-18:30

Discussion

 

Saturday, November 29

08:30-10:00 GOOD MORNING ROME PLENARY LECTURE HALL A
Capsule Endometriosis is a chronic disease that affects all phases of reproductive life
Chairpersons

Bart Fauser, Netherlands
Jacques Donnez, Belgium
08:30-08:55

Endometriosis before and during pregnancy
Paolo Vercellini, Italy
08:55-09:00 Discussion
09:00-10:30 HI-TECH IVF HALL A
Capsule New technologies keep on emerging in IVF. The difficulty remains to assess the true added value. And finding the right balance between premature introduction into the clinic, versus being over cautious and denying patients interventions which does improve outcomes
Chairpersons Bart Fauser, Netherlands
Jacques Donnez, Belgium
09:00-09:25

Automation in IVF: Where are we heading
Laura Rienzi, Italy
09:25-09:30

Discussion
09:30-09:55

Imaging of early embryos using a light-sheet on-a-chip device: A proof-of-concept
Fabrizio Horta, Australia
09:55-10:00 Discussion
10:05-10:25

Prospects for use of bioengineered tissue from stem cells in gynecology
Mats Brännström, Sweden
10:25-10:30 Discussion

 

10:30-11:00 Coffee break, visit the exhibition, and e-poster viewing

 

11:00-12:30 Q&A HALL A 
Capsule Expert views on hot controversial issues
Chairpersons Bart Fauser, Netherlands
Zion Ben Rafael, Israel
Discussants

Laura Rienzi, Italy
Anja Pinborg, Denmark
Rita Vassena, Spain
Edgardo Somigliana, Italy
Norbert Gleicher, USA
Pasquale Patrizio, USA

Q&A

  1. The uterine microbiome: Are the studies credible. Can it predict implantation?
  2. Artificial cycle for FET: Will it survive?
  3. Are we settled on the best protocol for FET
  4. What are the indications for day 3 versus day 5 embryo transfer?
  5. Will AI replace human involvement in IVF?
  6. Timings and strategies in the IVF lab vs. outcomes? (time from OPU to IVF/ ICSI, should ICSI be used for every case? What sperm selection method is best?, calcium ionophore?)?
  7. PRP: for ovarian rejuvenation? For improving implantation? Any real proof of its efficacy?
  8. Add-ons which one works?
  9. What to do when a high percentage of eggs are consistently immature?
  10. When the fertilization rate is low, When blastulation rates are low?

 

12:30-13:30 Lunch break, visit the exhibition, and e-poster viewing

 

13:30-15:00 PERSONALIZED MEDICINE HALL A
Capsule How to personalize when we have only a few parameters to take care of?
Chairpersons Dominique de Ziegler, France
Rene Frydman, France

13:30-13:50

 Prediction models
Bart Fauser, Netherlands

13:50-14:00

 Discussion

14:00-14:30

14:00
14:10
14:20

Debate: Ovarian stimulation

Proposition: Personalization of ovarian stimulation Enrico Papaleo, Italy
Opposition: Edgardo Somigliana, Italy
Discussion

14:30-15:00

14:30
14:40
14:50

Debate: Should we treat istmocele in infertile women, and how?

Yes: Amerigo Vitagliano, Italy
No: Mauro Cozzolino, Italy
Discussion
18:20-18:30 Discussion

 

15:00-16:30 HIGH AND LOW RESPONDERS HALL A 
Capsule Ovarian stimulation represents a topic of ongoing concern and progress. How many follicles/ oocytes should we aim for securing optimal success rates; and when is response too low (indicating poor outcomes), or too high associated with increased complication chances and patient burden. And how should this be handled, both in terms of prevention and treatment
Chairpersons

Zion Ben Rafael, Israel
Edgardo Somigliana, Italy
15:00-15:15

Infertility treatment in women with PCOS – what does the evidence say?
Basil Tarlatzis, Greece
15:15-15:20

Discussion
15:20-15:35

Ovarian stimulation protocols from ultra-long to short: What works best?
Alberto Vaiarelli, Italy
15:35-15:40

Discussion
15:40-15:55

Stimulation of DOR patient
Stratis Kolibianakis, Greece
15-55-16:00 Discussion
16:00-16:30

16:00
16:10
16:20

Debate: LH activity in ovarian stimulation: Is it still necessary?

Yes: Paul Pirtea, France
No: Carlo Alviggi, Italy
Discussion

 

Skip to content